Table of Contents
Chapter 1. Research Methodology
1.1. Research Methodology
1.2. List of Data Sources
Chapter 2. Pricing/Cost Structure Analysis
2.1. Clinical Trials Market Overview
2.2. Clinical Trial Cost Structure Analysis
2.2.1. Clinical Trial Cost Structure Analysis, by Phase
2.2.2. Clinical Trial Cost Structure Analysis, by Key Therapeutic Area
2.3. Contract Research Organizations (CRO) Cost Structure Analysis
2.3.1. Average Cost Structure for key Component
2.3.1.1. Direct Cost
2.3.1.1.1. Data Management
2.3.1.1.2. Regulatory Affairs
2.3.1.1.3. Site Identification and Selection
2.3.1.1.4. Site Initiation and Activation
2.3.1.1.5. Site Contracting and Payments
2.3.1.1.6. Site Management
2.3.1.1.7. Clinical Monitoring
2.3.1.1.8. Logistics
2.3.1.1.9. Medical Writing
2.3.1.1.10. Site Close-out
2.3.1.1.11. Project Management
2.3.1.1.12. Statistics
2.3.1.1.13. Quality Control
2.3.1.2. In-direct Cost
2.4. Comparative Pricing Analysis, by Region
2.4.1. North America
2.4.2. Europe
2.4.3. Asia Pacific
2.4.4. Latin America
2.4.5. MEA
2.5. Factors Impacting Service Pricing/Cost Structure
2.6. Challenge Analysis
2.7. Opportunity Analysis
Chapter 3. Pricing Model Analysis for Healthcare Contract Research Organizations (CRO)
3.1. Fixed-Price Model
3.1.1. Model Description
3.1.2. Key Components
3.1.3. Mechanism
3.1.4. Advantages
3.1.5. Disadvantages
3.1.6. Key Application Areas
3.2. Time and Materials (T&M) Model
3.3. Performance-Based Pricing Model
3.4. Cost-Plus Model
3.5. Unit-Based Pricing
3.6. Milestone-Based Pricing
3.7. Risk-Sharing Model
3.8. Retainer Model
3.9. Subscription Model
3.10. Hybrid Pricing Model